| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.089 | 0.004 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.087 | 0.004 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.005 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |